When Less Is More, None Can Be Even Better: Rethinking Routine Follow‐Up of Chronic Disease Exemplified With Rheumatoid Arthritis

Documenti analoghi

• The Risk of Lung Cancer in Rheumatoid Arthritis and Rheumatoid Arthritis–Associated Interstitial Lung Disease
  di: Rebecca T. Brooks, et al.
  Pubblicazione: (2024)
• Air Pollution's Hidden Toll: Risks for Rheumatoid Arthritis and Rheumatoid Arthritis–Associated Lung Disease
  di: Sofia Ajeganova, et al.
  Pubblicazione: (2025)
• Associations of Fire Smoke and Other Pollutants With Incident Rheumatoid Arthritis and Rheumatoid Arthritis–Associated Interstitial Lung Disease
  di: Vanessa L. Kronzer, et al.
  Pubblicazione: (2025)
• Associations Between Changes in Pain Sensitization and Disease Activity Following Disease‐Modifying Antirheumatic Drug Therapy in Established Rheumatoid Arthritis
  di: Burcu Aydemir, et al.
  Pubblicazione: (2025)
• Peripheral Biomarker Signatures in Rheumatoid Arthritis–Associated Interstitial Lung Disease
  di: Austin M. Wheeler, et al.
  Pubblicazione: (2025)